Your browser doesn't support javascript.
loading
Real-world evidence of mesenchymal stem cell therapy in knee osteoarthritis: a large prospective two-year case series.
Freitag, Julien; Wickham, James; Shah, Kiran; Tenen, Abi.
Affiliation
  • Freitag J; Charles Sturt University, Orange, NSW, 2800, Australia.
  • Wickham J; Magellan Stem Cells, Box Hill, Victoria, 3129, Australia.
  • Shah K; Melbourne Stem Cell Centre Research, Box Hill, Victoria, 3129, Australia.
  • Tenen A; Charles Sturt University, Orange, NSW, 2800, Australia.
Regen Med ; 17(6): 355-373, 2022 06.
Article in En | MEDLINE | ID: mdl-35411799
The aim of this study was to assess the benefit of stem cell therapy in the treatment of mild to severe knee osteoarthritis. A total of 329 study participants with painful knee osteoarthritis undertook stem cell therapy and were followed up for two years. Stem cell therapy was well tolerated and safe. Significant pain and functional improvement were observed in all of the participant groups including those with severe bone-on-bone osteoarthritis. Participants' age and weight did not influence the clinical outcome. This study shows that stem cell therapy is an effective, safe and long-lasting treatment for knee osteoarthritis and greatly reduces knee pain and improves the function of the knee. Stem cell therapy may delay or prevent knee replacement surgery and result in significant global health and economic benefit.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis, Knee / Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells Type of study: Observational_studies Limits: Humans Language: En Journal: Regen Med Year: 2022 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis, Knee / Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells Type of study: Observational_studies Limits: Humans Language: En Journal: Regen Med Year: 2022 Document type: Article Affiliation country: Australia Country of publication: United kingdom